NGT: Saline, Vascular Access Flush
What it covers
Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use.
FDA’s definition of product code NGT, from the Product Classification database.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K250884 | 0.9 % Sodium Chloride Injection, USP, BD PosiFlush SP Syringe | Becton, Dickinson and Company | Dec 2, 2025 | Traditional |
| K233623 | Praxiject SP 0.9% NaCl | Medxl, Inc. | Feb 27, 2024 | Traditional |
| K231724 | Flush Syringe (Prefilled 0.9% normal saline solution) | Spm Medicare Pvt. , Ltd. | Nov 9, 2023 | Traditional |
| K231363 | Hantech Pre-filled 0.9% Normal Saline Flush Syringes (Models PFS-1003, PFS-1005, PFS-1010) | Hantech Medical Device Co., Ltd. | Sep 27, 2023 | Traditional |
| K230756 | TK Pre-Filled Normal Saline Flush Syringe | Anhui Tiankang Medical Technology Co., Ltd. | Aug 12, 2023 | Traditional |
| K223584 | Pre-Filled Normal Saline Flush Syringe | Anhui Tianyang Pharmaceutical Co., Ltd. | Aug 12, 2023 | Traditional |
| K231161 | 0.9% Sodium Chloride Injection, USP BD PosiFlush SF Saline Flush Syringe | Becton, Dickinson and Company | Jul 21, 2023 | Traditional |
| K231754 | Praxiject 0.9% NaCl | Medxl, Inc. | Jul 13, 2023 | Special |
| K214080 | Pentaflush | Pentaferte Italia S.R.L. | Jul 20, 2022 | Traditional |
| K213522 | AMSafe Pre-Filled Normal Saline Flush Syringe | Amsino International, Inc. | Mar 22, 2022 | Traditional |
Clearances by year
30 NGT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2025 | 1 | 253 |
| 2024 | 1 | 106 |
| 2023 | 6 | 142 |
| 2022 | 2 | 172 |
| 2020 | 2 | 126 |
| 2019 | 2 | 163 |
| 2018 | 1 | 239 |
| 2017 | 2 | 246 |
| 2016 | 1 | 123 |
| 2015 | 1 | 221 |
| 2014 | 3 | 87 |
| 2013 | 1 | 307 |
| 2012 | 4 | 106 |
| 2011 | 3 | 219 |
Who submits
18 applicants cleared a NGT device since 2011. 63% of the clearances went to applicants in United States, then Canada (20%), China (10%) and India (3%). By type: Traditional 73% and Special 27%.
| Applicant | Clearances since 2011 |
|---|---|
| Becton, Dickinson and Company | 5 |
| Am USA | 4 |
| Medxl, Inc. | 4 |
| Amsino International, Inc. | 2 |
| Medline Industries, Inc. | 2 |
| Anhui Tiankang Medical Technology Co., Ltd. | 1 |
| Anhui Tianyang Pharmaceutical Co., Ltd. | 1 |
| Becton, Dickinson & CO | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 880.5200.
Standards
21 CFR 880.5200 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NGT clearances declared.
Ask about NGT
Questions about NGT
What is FDA product code NGT?
Product code NGT, “Saline, Vascular Access Flush” in FDA's classification database, is a Class II device type under 21 CFR 880.5200 (intravascular catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 40 clearances under NGT, 30 of them since 2011.
How many 510(k) clearances are there under NGT?
FDA’s 510(k) database listed 40 clearances under NGT as of Oct 29, 2026, 30 of them decided since 2011; the most recent decision was Dec 2, 2025. The Predicate Finder searches the live database.
How long does FDA take to clear a NGT 510(k)?
For the 1 NGT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 253 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most NGT clearances?
Since 2011: Becton, Dickinson and Company (5), Am USA (4), Medxl, Inc. (4), Amsino International, Inc. (2) and Medline Industries, Inc. (2). 18 applicants have cleared a NGT device in that time.